References
Goldfarb SB, Kamer SA, Oppong BA, et al. Fertility preservation for the young breast cancer patient. Ann Surg Oncol. 2016;23(5):1530–6.
Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC. Adolescents and young adults with breast cancer have more aggressive disease and treatment than patients in their forties. Ann Surg Oncol. 2019;26(12):3920–30.
Crown A, Muhsen S, Zabor EC, et al. Does use of neoadjuvant chemotherapy affect the decision to pursue fertility preservation options in young women with breast cancer? Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08883-y.
Kim J, Oktay K, Gracia C, Lee S, Morse C, Mersereau JE. Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer. Fertil Steril. 2012;97(3):671–76.
Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23(19):4347–53.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have no conflict of interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This ASO Author Reflections is a brief invited commentary on the article, “Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?” Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08883-y.
Rights and permissions
About this article
Cite this article
Crown, A., Gemignani, M.L. ASO Author Reflections: Impact of Neoadjuvant Chemotherapy on Exploration of Fertility Preservation. Ann Surg Oncol 27 (Suppl 3), 699–700 (2020). https://doi.org/10.1245/s10434-020-08917-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08917-5